Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Hyperoxic Swim Stress
NCT04732247Phase 2Completed
- Sponsor
- Institute for Human and Machine Cognition
- Start
- Feb 2022
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in oxidative stress, inflammation, sponsored by Institute for Human and Machine Cognition. Started Feb 2022; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
oxidative stressinflammation
Beyond the preview
Go deeper on NCT04732247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04732247.